When this was written — On 11 September 2026. The figures are as at that date or earlier and have not been updated since.
The titanium tug-of-war
IperionX has become a battleground between short sellers betting on a deeper slide and directors putting their own capital on the line. Over the last three months, the stock has dropped 40.7%, while short interest climbed steadily to a 90-day peak of 10.76%. This puts the titanium developer well above its peer sector average of 9.64% short interest, indicating a concentrated bet against the company's scaling plans.
The price-shorts correlation over the past 30 days sits at -0.393. As the stock fell, short sellers aggressively increased their positions. But the board isn't sitting quietly. Non-Executive Chairman Todd Hannigan and Director Tony Tripeny have led a massive A$1.97 million insider buying spree to defend the stock.
Inside the A$1.97 million board defence
The insider buying started immediately after a sharp 15.6% drop in the share price on July 8, 2026 1. Two days later, on July 10, Todd Hannigan purchased A$1,881,176.10 worth of shares on-market 2. Tony Tripeny followed on July 14 with a A$92,300.91 purchase 3.
This isn't the first time insiders have bought the dip 45, but the scale of Hannigan's July transaction represents a significant personal bet on the company's domestic US manufacturing strategy. It signals that while the market sold off heavily during July, those closest to the operations saw a disconnect between the share price and the asset value.
The data behind the short build-up
The short position did not build overnight. The 90-day average short interest was 9.23%, but the current 10.76% mark represents the absolute peak of the cycle. The short slope has been steepest over the last week, rising at 0.11 percentage points per day, compared to a longer-term 90-day slope of 0.02 percentage points per day.
With the stock down 50.2% over six months, short sellers have found a highly profitable trade. The correlation of -0.393 over 30 days shows that short sellers were actively adding to their positions as the price fell from its highs.
Because short interest reporting is subject to a T+4 ASIC delay, the 10.76% figure reflects positions held late last week rather than yesterday. However, the trajectory suggests that the bear case is still gathering momentum despite the board's defensive buying.
US defence contracts and the 2030 runway
The short sellers are targeting a company with substantial, albeit long-dated, operational targets. In its 2025 Annual Report, IperionX outlined a target production capacity of 10,000 tonnes per annum (tpa) by 2030, with an interim expansion to 1,400 tpa by mid-2027 R6.
While the market has focused on the immediate capital requirements and execution risks of this expansion, the company has secured non-dilutive funding to support its plans. On August 30, 2026, IperionX secured up to US$25.4 million for a US Army Task Order 7. This followed media reports in July highlighting how US defence funding is designed to strengthen the domestic titanium supply chain 89.
To better align with this customer base, the company announced plans on August 2, 2026, to redomicile to the United States 10. This corporate shift, combined with the 24/7 production ramp-up reported in earlier quarters 1112, forms the core of the long-term bull case.
A clear line in the sand
The conflict between short sellers and the board is now clearly defined. Short sellers are betting that the capital-intensive scaling phase and the planned US redomiciliation 10 will continue to depress the share price in the medium term.
The board, through a combined A$1.97 million investment 32, has drawn a line in the sand. They are backing a pipeline backed by US$25.4 million in military contracts 7 and a 10,000 tpa production target R6.
The board has spent nearly A$2 million to signal that the market is mispricing the titanium transition.
Whether the short sellers are forced to cover or the directors' buying spree simply catches a falling knife remains the central question for the register.
- 2026-07-08IPX shares plunge 15.6%[ref-1]
- 2026-07-10Chairman Todd Hannigan buys A$1.88M[ref-2]
- 2026-07-14Director Tony Tripeny buys A$92k[ref-3]
- 2026-08-02US redomiciliation announced[ref-10]
- 2026-08-30US$25.4M Army Task Order secured[ref-7]